Add Company
Join Now

NASTAD Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

NonProfit

Industry

Estimated Revenue & Valuation

  • NASTAD's estimated annual revenue is currently $7.5M per year.(i)
  • NASTAD's estimated revenue per employee is $66,964

Employee Data

  • NASTAD has 112 Employees.(i)
  • NASTAD grew their employee count by -5% last year.

NASTAD's People

NameTitleEmail/Phone
1
Associate Director Health Systems IntegrationReveal Email/Phone
2
Executive DirectorReveal Email/Phone
3
Associate Director, Grants & ComplianceReveal Email/Phone
4
Director, CommunicationsReveal Email/Phone
5
Director, Health Systems IntegrationReveal Email/Phone
6
Senior Director, Syndemic ApproachesReveal Email/Phone
7
Senior Director, Public Health SystemsReveal Email/Phone
8
Associate Director, Drug User HealthReveal Email/Phone
9
Director Health Education and EquityReveal Email/Phone
10
Senior Director, Policy & Legislative AffairsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.5M578%N/AN/A
#2
$3.5M240%N/AN/A
#3
$35M140067%N/AN/A
#4
$15M1040%N/AN/A
#5
$75M17316%N/AN/A
#6
$7.5M497%N/AN/A
#7
$15M278N/AN/AN/A
#8
$75M34634%N/AN/A
#9
$15M1771%N/AN/A
#10
N/A2229%N/AN/A
Add Company

What Is NASTAD?

NASTAD is a non-partisan non-profit association that represents public health officials who administer HIV and hepatitis health care, prevention, education and supportive service programs funded by state and federal governments in all 50 U.S. states, the District of Columbia, Puerto Rico, the U.S. Virgin Islands and the U.S. Pacific Islands. NASTAD also supports partner governments in Africa, the Central America region, and the Caribbean region. NASTAD's vision is a world free of HIV and viral hepatitis.

keywords:N/A

N/A

Total Funding

112

Number of Employees

$7.5M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16.2M11230%$23.8M
#2
$20.9M11217%N/A
#3
$26.2M1126%N/A
#4
$11.5M11312%N/A
#5
$16.4M1138%$10M